DEA schedule
Is cabergoline a controlled substance?
Federal schedule for cabergoline from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Cabergoline is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and cabergoline is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted cabergoline?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 12 prescription listings from 9 labelers, none with a DEA schedule |
| DEA controlled substances list | cabergoline is not on the list |
Cabergoline NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0093-5420 | Cabergoline | tablet | .5 mg/1 | Teva Pharmaceuticals USA, Inc. | None |
| 23155-823 | Cabergoline | tablet | .5 mg/1 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
| 27808-315 | CABERGOLINE | tablet | .5 mg/1 | Cranbury Pharmaceuticals, LLC | None |
| 50090-3157 | Cabergoline | tablet | .5 mg/1 | A-S Medication Solutions | None |
| 50090-5834 | Cabergoline | tablet | .5 mg/1 | A-S Medication Solutions | None |
| 50090-6596 | Cabergoline | tablet | .5 mg/1 | A-S Medication Solutions | None |
| 50090-7642 | Cabergoline | tablet | .5 mg/1 | A-S Medication Solutions | None |
| 50742-118 | Cabergoline | tablet | .5 mg/1 | Ingenus Pharmaceuticals, LLC | None |
| 59762-1005 | Cabergoline | tablet | .5 mg/1 | Mylan Pharmaceuticals Inc. | None |
| 69238-2693 | Cabergoline | tablet | .5 mg/1 | Amneal Pharmaceuticals NY LLC | None |
| 70069-824 | CABERGOLINE | tablet | .5 mg/1 | Somerset Therapeutics, LLC | None |
| 70512-860 | Cabergoline | tablet | .5 mg/1 | SOLA Pharmaceuticals, LLC | None |
Questions
Is cabergoline a controlled substance?
No. Cabergoline is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and cabergoline is not on the DEA controlled substances list.
Is cabergoline a narcotic?
No. Cabergoline is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Ergot Derivative.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.